FI74467C - Foerfarande foer framstaellning av 1,2,3,10-tetrahydro-10-oxo-cyklopenta/d/pyrido/1,2-a/pyrimidin- och 1,2,3,4-tetrahydro-11-oxo-11h-pyrido/2,1-b/kinazolinderivat. - Google Patents
Foerfarande foer framstaellning av 1,2,3,10-tetrahydro-10-oxo-cyklopenta/d/pyrido/1,2-a/pyrimidin- och 1,2,3,4-tetrahydro-11-oxo-11h-pyrido/2,1-b/kinazolinderivat. Download PDFInfo
- Publication number
- FI74467C FI74467C FI831426A FI831426A FI74467C FI 74467 C FI74467 C FI 74467C FI 831426 A FI831426 A FI 831426A FI 831426 A FI831426 A FI 831426A FI 74467 C FI74467 C FI 74467C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- pyrido
- tetrahydro
- compound
- group
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 110
- -1 amino, nitro, amino Chemical group 0.000 claims description 73
- 239000000203 mixture Substances 0.000 claims description 31
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 21
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 16
- 125000003277 amino group Chemical group 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- 150000002431 hydrogen Chemical class 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- DLEKPPJSDIKZAN-UHFFFAOYSA-N 1,2-dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10 -one Chemical compound N1=C2C=CC=CN2C(=O)C2=C1CCC2 DLEKPPJSDIKZAN-UHFFFAOYSA-N 0.000 claims description 3
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims description 2
- KIDSCEBUTHOOGI-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrido[2,1-b]quinazolin-11-one Chemical class N1=C2C=CC=CN2C(=O)C2=C1CCCC2 KIDSCEBUTHOOGI-UHFFFAOYSA-N 0.000 claims 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- RYXPMWYHEBGTRV-UHFFFAOYSA-N Omeprazole sodium Chemical compound [Na+].N=1C2=CC(OC)=CC=C2[N-]C=1S(=O)CC1=NC=C(C)C(OC)=C1C RYXPMWYHEBGTRV-UHFFFAOYSA-N 0.000 claims 1
- 241000277284 Salvelinus fontinalis Species 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 239000002244 precipitate Substances 0.000 description 26
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 24
- 239000000460 chlorine Substances 0.000 description 20
- UPGZAERNNNZSPM-UHFFFAOYSA-N quinazoline-8-carboxylic acid Chemical compound N1=CN=C2C(C(=O)O)=CC=CC2=C1 UPGZAERNNNZSPM-UHFFFAOYSA-N 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 17
- 229910052801 chlorine Inorganic materials 0.000 description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 15
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 14
- 238000010992 reflux Methods 0.000 description 13
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 230000007935 neutral effect Effects 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 11
- 235000011054 acetic acid Nutrition 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- LBMGFLVZIOZDHZ-UHFFFAOYSA-N 4h-pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1C=CN=C2C=CC(C(=O)O)=CN21 LBMGFLVZIOZDHZ-UHFFFAOYSA-N 0.000 description 7
- 208000007107 Stomach Ulcer Diseases 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 201000005917 gastric ulcer Diseases 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- SORCQIVSPYWDSM-UHFFFAOYSA-N 11-oxopyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC=C2C(=O)N(C=C(C(=O)O)C=C3)C3=NC2=C1 SORCQIVSPYWDSM-UHFFFAOYSA-N 0.000 description 2
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 2
- KRNUKLBBDTUZTB-UHFFFAOYSA-N 3-benzylidene-1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=C1 KRNUKLBBDTUZTB-UHFFFAOYSA-N 0.000 description 2
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- LFQHFJNMSCYEPD-UHFFFAOYSA-N 4-[(3-chlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC(Cl)=C1 LFQHFJNMSCYEPD-UHFFFAOYSA-N 0.000 description 2
- YPMRRQPOABVGQI-UHFFFAOYSA-N 4-[(4-ethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(OCC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 YPMRRQPOABVGQI-UHFFFAOYSA-N 0.000 description 2
- GNVXINQVPKWACR-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(N(C)C)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 GNVXINQVPKWACR-UHFFFAOYSA-N 0.000 description 2
- QHRQUMBXAYKEMS-UHFFFAOYSA-N 4-benzylidene-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=C1 QHRQUMBXAYKEMS-UHFFFAOYSA-N 0.000 description 2
- AADABAOQXSLRGV-UHFFFAOYSA-N 7-chloro-1,2,3,10-tetrahydro-cyclopenta[d]pyrido[1,2-a]pyrimidine-10-one Chemical compound O=C1N2C=C(Cl)C=CC2=NC2=C1CCC2 AADABAOQXSLRGV-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FCYXYBUZIRUSAB-UHFFFAOYSA-N CCOC(C(CC1=CC2=CC=CC=C2)C(C2)=C1N=C1N2C=CC=C1)=O Chemical compound CCOC(C(CC1=CC2=CC=CC=C2)C(C2)=C1N=C1N2C=CC=C1)=O FCYXYBUZIRUSAB-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- VEJYSWPAHQBHFD-UHFFFAOYSA-N NC(C(C=C1)=CN2C1=NC(C(CC1)=CC3=CC=CC=C3)=C1C2)=O Chemical compound NC(C(C=C1)=CN2C1=NC(C(CC1)=CC3=CC=CC=C3)=C1C2)=O VEJYSWPAHQBHFD-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- OAAYTKRDXAOZTG-UHFFFAOYSA-N quinazoline-8-carboxylic acid;hydrochloride Chemical compound Cl.N1=CN=C2C(C(=O)O)=CC=CC2=C1 OAAYTKRDXAOZTG-UHFFFAOYSA-N 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- KQUMXMMDBYHFFT-UHFFFAOYSA-N 1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound O=C1N2C=C(C(=O)O)C=CC2=NC2=C1CCC2 KQUMXMMDBYHFFT-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- WCFAPJDPAPDDAQ-UHFFFAOYSA-N 1,2-dihydropyrimidine Chemical compound C1NC=CC=N1 WCFAPJDPAPDDAQ-UHFFFAOYSA-N 0.000 description 1
- IRLCAMXBIOOIFY-UHFFFAOYSA-N 10,12-dichloro-6-[(2,6-dichlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=C(Cl)C3=NC=2C1=CC1=C(Cl)C=CC=C1Cl IRLCAMXBIOOIFY-UHFFFAOYSA-N 0.000 description 1
- NVAXNBLCTQVFHS-UHFFFAOYSA-N 11-oxo-1,2,3,4-tetrahydropyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCCC2=C1N=C1C=CC(C(=O)O)=CN1C2=O NVAXNBLCTQVFHS-UHFFFAOYSA-N 0.000 description 1
- SJUOUSYZSRKBIJ-UHFFFAOYSA-N 11-oxo-4-(thiophen-2-ylmethylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CS1 SJUOUSYZSRKBIJ-UHFFFAOYSA-N 0.000 description 1
- CXQWHTBPWGPBFQ-UHFFFAOYSA-N 12-bromo-6-[(2,6-dichlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound ClC1=CC=CC(Cl)=C1C=C1C(N=C2N(C=C(Br)C=C2)C2=O)=C2CC1 CXQWHTBPWGPBFQ-UHFFFAOYSA-N 0.000 description 1
- WAMLQLDGCXNZCB-UHFFFAOYSA-N 12-chloro-6-[(2,3,4-trimethoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=C(OC)C(OC)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 WAMLQLDGCXNZCB-UHFFFAOYSA-N 0.000 description 1
- GAPDMJGIXDHEQV-UHFFFAOYSA-N 12-chloro-6-[(2-methylphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 GAPDMJGIXDHEQV-UHFFFAOYSA-N 0.000 description 1
- LAFMITCPYCDUPM-UHFFFAOYSA-N 12-chloro-6-[(3,4-dichlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=CC3=NC=2C1=CC1=CC=C(Cl)C(Cl)=C1 LAFMITCPYCDUPM-UHFFFAOYSA-N 0.000 description 1
- VLVMBOQBWMVVAP-UHFFFAOYSA-N 12-chloro-6-[(3-chlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound ClC1=CC=CC(C=C2C3=C(C(N4C=C(Cl)C=CC4=N3)=O)CC2)=C1 VLVMBOQBWMVVAP-UHFFFAOYSA-N 0.000 description 1
- WLVUBKLIGTZCBF-UHFFFAOYSA-N 12-chloro-6-[(4-chlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(Cl)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 WLVUBKLIGTZCBF-UHFFFAOYSA-N 0.000 description 1
- GUTMYXDYGYVOQA-UHFFFAOYSA-N 12-chloro-6-[(4-methylphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 GUTMYXDYGYVOQA-UHFFFAOYSA-N 0.000 description 1
- FIBWTOCNGZCBQN-UHFFFAOYSA-N 2-(diethylamino)ethyl 4-benzylidene-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylate Chemical compound C1CCC=2C(=O)N3C=C(C(=O)OCCN(CC)CC)C=CC3=NC=2C1=CC1=CC=CC=C1 FIBWTOCNGZCBQN-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 150000003930 2-aminopyridines Chemical class 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
- NEJCUAZSPRZUOE-UHFFFAOYSA-N 3-benzylidene-5-methoxy-1,2,3,10-tetrahydro-cyclopenta[d]pyrido[1,2-a]pyrimidine-10-one Chemical compound COC1=CC=CN(C(C=2CC3)=O)C1=NC=2C3=CC1=CC=CC=C1 NEJCUAZSPRZUOE-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- MTQPILPPIDNQQX-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-ylmethylidene)-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=C2OCOC2=CC(C=C2C=3N=C4C=CC(=CN4C(=O)C=3CCC2)C(=O)O)=C1 MTQPILPPIDNQQX-UHFFFAOYSA-N 0.000 description 1
- NZPIAWRECUJCGF-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(Cl)C=C1Cl NZPIAWRECUJCGF-UHFFFAOYSA-N 0.000 description 1
- PQQPWSKHNMAURX-UHFFFAOYSA-N 4-[(2,5-dimethylphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CC1=CC=C(C)C(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 PQQPWSKHNMAURX-UHFFFAOYSA-N 0.000 description 1
- MEBGECTZRYZCPD-UHFFFAOYSA-N 4-[(2-chlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=C1Cl MEBGECTZRYZCPD-UHFFFAOYSA-N 0.000 description 1
- HMXLLKVGVZWJIL-UHFFFAOYSA-N 4-[(2-ethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CCOC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 HMXLLKVGVZWJIL-UHFFFAOYSA-N 0.000 description 1
- IYPZGKADMRNZIS-UHFFFAOYSA-N 4-[(2-methylphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 IYPZGKADMRNZIS-UHFFFAOYSA-N 0.000 description 1
- FSADGQJCNUPMIA-UHFFFAOYSA-N 4-[(3-ethoxy-2-methoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CCOC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1OC FSADGQJCNUPMIA-UHFFFAOYSA-N 0.000 description 1
- ACDGPSFNSGPUJE-UHFFFAOYSA-N 4-[(3-ethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CCOC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 ACDGPSFNSGPUJE-UHFFFAOYSA-N 0.000 description 1
- XGIGFMCNYPQGIC-UHFFFAOYSA-N 4-[(3-methoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 XGIGFMCNYPQGIC-UHFFFAOYSA-N 0.000 description 1
- ISZPLXJYYVDYOJ-UHFFFAOYSA-N 4-[(4-aminophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(N)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 ISZPLXJYYVDYOJ-UHFFFAOYSA-N 0.000 description 1
- VBFVPBOTRXXBTR-UHFFFAOYSA-N 4-[(4-chlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(Cl)C=C1 VBFVPBOTRXXBTR-UHFFFAOYSA-N 0.000 description 1
- BAHDARMCCVCUAE-UHFFFAOYSA-N 4-[(4-fluorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(F)C=C1 BAHDARMCCVCUAE-UHFFFAOYSA-N 0.000 description 1
- OUTXTHGSFTULJT-UHFFFAOYSA-N 4-[(4-methoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 OUTXTHGSFTULJT-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- VFMCUTPRJLZEEW-UHFFFAOYSA-N 4h-pyrido[1,2-a]pyrimidine Chemical class C1=CC=CN2CC=CN=C21 VFMCUTPRJLZEEW-UHFFFAOYSA-N 0.000 description 1
- FSZXRXAGYGVFLN-UHFFFAOYSA-N 6-[(3-chlorophenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC(Cl)=C1 FSZXRXAGYGVFLN-UHFFFAOYSA-N 0.000 description 1
- LDNJLQJITIAGLI-UHFFFAOYSA-N 6-[(4-methoxyphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 LDNJLQJITIAGLI-UHFFFAOYSA-N 0.000 description 1
- CNLJKQJZTLFBBG-UHFFFAOYSA-N 6-benzylidene-10,12-dichloro-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=C(Cl)C3=NC=2C1=CC1=CC=CC=C1 CNLJKQJZTLFBBG-UHFFFAOYSA-N 0.000 description 1
- YOEDRESVXYAKCK-UHFFFAOYSA-N 6-benzylidene-12-bromo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Br)C=CC3=NC=2C1=CC1=CC=CC=C1 YOEDRESVXYAKCK-UHFFFAOYSA-N 0.000 description 1
- WQGFRQSRLRMVRM-UHFFFAOYSA-N 6-benzylidene-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carbonitrile Chemical compound C1=2N=C3C=CC(C#N)=CN3C(=O)C=2CCC1=CC1=CC=CC=C1 WQGFRQSRLRMVRM-UHFFFAOYSA-N 0.000 description 1
- MNDQKOHKXQFUTG-UHFFFAOYSA-N 7-methyl-1,2,3,10-tetrahydro-cyclopenta[d]pyrido[1,2-a]pyrimidine-10-one Chemical compound O=C1N2C=C(C)C=CC2=NC2=C1CCC2 MNDQKOHKXQFUTG-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000000104 Arthus reaction Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- CLFHWFOMJAPJNQ-UHFFFAOYSA-N C(C)OC(=O)C=1C=CC=2N(CC=CN=2)C=1 Chemical compound C(C)OC(=O)C=1C=CC=2N(CC=CN=2)C=1 CLFHWFOMJAPJNQ-UHFFFAOYSA-N 0.000 description 1
- WWBIVGQTZYXLTA-UHFFFAOYSA-N C1=CC=C2N=C3N(C=C21)C=C(C=C3)C(=O)O Chemical compound C1=CC=C2N=C3N(C=C21)C=C(C=C3)C(=O)O WWBIVGQTZYXLTA-UHFFFAOYSA-N 0.000 description 1
- NDPJFELNVXRTTO-UHFFFAOYSA-N C1CC(=CC2=CC(=CC=C2)O)C3=C1CN4C=C(C=CC4=N3)C(=O)O Chemical compound C1CC(=CC2=CC(=CC=C2)O)C3=C1CN4C=C(C=CC4=N3)C(=O)O NDPJFELNVXRTTO-UHFFFAOYSA-N 0.000 description 1
- GMKRXWBETRFCRI-UHFFFAOYSA-N C1CC(=CC2=CC=CC=C2)C3=C1CN4C=C(C=CC4=N3)C(=O)O Chemical compound C1CC(=CC2=CC=CC=C2)C3=C1CN4C=C(C=CC4=N3)C(=O)O GMKRXWBETRFCRI-UHFFFAOYSA-N 0.000 description 1
- DWEVPTFZAMXEMX-UHFFFAOYSA-N C1CNC23CC=CC2=NC=NC3=C1 Chemical class C1CNC23CC=CC2=NC=NC3=C1 DWEVPTFZAMXEMX-UHFFFAOYSA-N 0.000 description 1
- PVQAMFCWKPYLNB-UHFFFAOYSA-N C=1C=CC2=NC=3N(C(C2=1)=O)CC=CC=3 Chemical compound C=1C=CC2=NC=3N(C(C2=1)=O)CC=CC=3 PVQAMFCWKPYLNB-UHFFFAOYSA-N 0.000 description 1
- JRYLSBTWAANDEJ-UHFFFAOYSA-N CC1=CC=CC=C1C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O Chemical compound CC1=CC=CC=C1C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O JRYLSBTWAANDEJ-UHFFFAOYSA-N 0.000 description 1
- IWQIYQZWCFLOEY-UHFFFAOYSA-N CCOC1=CC=CC(=C1)C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O Chemical compound CCOC1=CC=CC(=C1)C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O IWQIYQZWCFLOEY-UHFFFAOYSA-N 0.000 description 1
- KUBHPVFTWDLNRN-UHFFFAOYSA-N COC1=CC=CC(=C1OC)C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O Chemical compound COC1=CC=CC(=C1OC)C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O KUBHPVFTWDLNRN-UHFFFAOYSA-N 0.000 description 1
- WERCHZIWLBTNMG-UHFFFAOYSA-N COC1=CC=CC=C1C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O Chemical compound COC1=CC=CC=C1C=C2CCC3=C2N=C4C=CC(=CN4C3)C(=O)O WERCHZIWLBTNMG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030201 Oesophageal ulcer Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- FDSGHYHRLSWSLQ-UHFFFAOYSA-N dichloromethane;propan-2-one Chemical compound ClCCl.CC(C)=O FDSGHYHRLSWSLQ-UHFFFAOYSA-N 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 150000002012 dioxanes Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000028299 esophageal disease Diseases 0.000 description 1
- 208000019064 esophageal ulcer Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- JHZPNBKZPAWCJD-UHFFFAOYSA-N ethyl 2-oxocyclopentane-1-carboxylate Chemical compound CCOC(=O)C1CCCC1=O JHZPNBKZPAWCJD-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- JZOYDIZTOZFWQA-UHFFFAOYSA-N methyl 4-[(4-aminophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylate Chemical compound C1CCC=2C(=O)N3C=C(C(=O)OC)C=CC3=NC=2C1=CC1=CC=C(N)C=C1 JZOYDIZTOZFWQA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- DORROBMBVJXJHA-UHFFFAOYSA-N methyl quinazoline-8-carboxylate Chemical compound N1=CN=C2C(C(=O)OC)=CC=CC2=C1 DORROBMBVJXJHA-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- YPLIFKZBNCNJJN-UHFFFAOYSA-N n,n-bis(ethylamino)ethanamine Chemical compound CCNN(CC)NCC YPLIFKZBNCNJJN-UHFFFAOYSA-N 0.000 description 1
- QAXZWHGWYSJAEI-UHFFFAOYSA-N n,n-dimethylformamide;ethanol Chemical compound CCO.CN(C)C=O QAXZWHGWYSJAEI-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical class N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8212429 | 1982-04-29 | ||
| GB8212429 | 1982-04-29 | ||
| GB8309259 | 1983-04-06 | ||
| GB838309259A GB8309259D0 (en) | 1983-04-06 | 1983-04-06 | Condensed cycloaliphatic derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI831426A0 FI831426A0 (fi) | 1983-04-26 |
| FI831426L FI831426L (fi) | 1983-10-30 |
| FI74467B FI74467B (fi) | 1987-10-30 |
| FI74467C true FI74467C (fi) | 1988-02-08 |
Family
ID=26282687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI831426A FI74467C (fi) | 1982-04-29 | 1983-04-26 | Foerfarande foer framstaellning av 1,2,3,10-tetrahydro-10-oxo-cyklopenta/d/pyrido/1,2-a/pyrimidin- och 1,2,3,4-tetrahydro-11-oxo-11h-pyrido/2,1-b/kinazolinderivat. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4521419A (enExample) |
| AT (1) | AT384808B (enExample) |
| AU (1) | AU557703B2 (enExample) |
| CA (1) | CA1192548A (enExample) |
| CH (1) | CH660485A5 (enExample) |
| CS (1) | CS233748B2 (enExample) |
| DE (1) | DE3315299A1 (enExample) |
| DK (1) | DK192683A (enExample) |
| ES (1) | ES8406476A1 (enExample) |
| FI (1) | FI74467C (enExample) |
| FR (1) | FR2526020B1 (enExample) |
| GR (1) | GR78546B (enExample) |
| HU (1) | HU188274B (enExample) |
| IL (1) | IL68505A (enExample) |
| IT (1) | IT1194215B (enExample) |
| LU (1) | LU84775A1 (enExample) |
| NL (1) | NL8301505A (enExample) |
| NO (1) | NO831503L (enExample) |
| NZ (1) | NZ204041A (enExample) |
| PH (1) | PH18388A (enExample) |
| PT (1) | PT76609B (enExample) |
| SE (1) | SE8302411L (enExample) |
| YU (1) | YU95583A (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63183581A (ja) * | 1985-10-03 | 1988-07-28 | Tokyo Tanabe Co Ltd | ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬 |
| CN112321465B (zh) * | 2019-07-18 | 2023-06-06 | 上海现代药物制剂工程研究中心有限公司 | 一种含苯基化合物、其中间体、制备方法及应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3965100A (en) * | 1975-02-26 | 1976-06-22 | E. R. Squibb & Sons, Inc. | 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives |
| US3935197A (en) * | 1975-05-16 | 1976-01-27 | E. R. Squibb & Sons, Inc. | 2-Styryl-4H-pyrido(1,2-a)pyrimidin-4-ones |
| US4033961A (en) * | 1975-10-07 | 1977-07-05 | Warner-Lambert Company | Pyrido[2-1-b]quinazolin-ones and their methods of preparation |
| DE2557425C2 (de) * | 1975-12-19 | 1987-03-19 | C.H. Boehringer Sohn, 6507 Ingelheim | 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
| HU174693B (hu) * | 1976-02-12 | 1980-03-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija kondensirovannykh proizvodnykh pirimidina |
| US4066767A (en) * | 1976-11-01 | 1978-01-03 | Warner-Lambert Company | 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them |
| HU182009B (en) * | 1977-08-19 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines |
| AU527931B2 (en) * | 1979-05-08 | 1983-03-31 | Farmitalia Carlo Erba S.P.A. | Substituted pyrido(1,2-a)pyrimidines |
| AT377586B (de) * | 1981-06-30 | 1985-04-10 | Erba Farmitalia | Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen |
-
1983
- 1983-04-22 ES ES521739A patent/ES8406476A1/es not_active Expired
- 1983-04-26 FI FI831426A patent/FI74467C/fi not_active IP Right Cessation
- 1983-04-26 IT IT20779/83A patent/IT1194215B/it active
- 1983-04-26 GR GR71210A patent/GR78546B/el unknown
- 1983-04-27 YU YU00955/83A patent/YU95583A/xx unknown
- 1983-04-27 HU HU831451A patent/HU188274B/hu not_active IP Right Cessation
- 1983-04-27 AU AU13991/83A patent/AU557703B2/en not_active Ceased
- 1983-04-27 LU LU84775A patent/LU84775A1/fr unknown
- 1983-04-27 DE DE19833315299 patent/DE3315299A1/de not_active Withdrawn
- 1983-04-27 IL IL68505A patent/IL68505A/xx unknown
- 1983-04-27 US US06/489,057 patent/US4521419A/en not_active Expired - Fee Related
- 1983-04-27 PH PH28824A patent/PH18388A/en unknown
- 1983-04-28 CS CS833005A patent/CS233748B2/cs unknown
- 1983-04-28 CH CH2286/83A patent/CH660485A5/de not_active IP Right Cessation
- 1983-04-28 FR FR8307052A patent/FR2526020B1/fr not_active Expired
- 1983-04-28 AT AT0154883A patent/AT384808B/de not_active IP Right Cessation
- 1983-04-28 SE SE8302411A patent/SE8302411L/xx not_active Application Discontinuation
- 1983-04-28 DK DK192683A patent/DK192683A/da not_active Application Discontinuation
- 1983-04-28 NO NO831503A patent/NO831503L/no unknown
- 1983-04-28 NL NL8301505A patent/NL8301505A/nl not_active Application Discontinuation
- 1983-04-28 CA CA000426896A patent/CA1192548A/en not_active Expired
- 1983-04-28 PT PT76609A patent/PT76609B/pt unknown
- 1983-04-28 NZ NZ204041A patent/NZ204041A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2526020B1 (fr) | 1986-03-21 |
| SE8302411L (sv) | 1983-10-30 |
| LU84775A1 (fr) | 1983-11-17 |
| PH18388A (en) | 1985-06-19 |
| US4521419A (en) | 1985-06-04 |
| NZ204041A (en) | 1985-02-28 |
| IL68505A0 (en) | 1983-07-31 |
| AT384808B (de) | 1988-01-11 |
| DK192683A (da) | 1983-10-30 |
| ES521739A0 (es) | 1984-07-01 |
| GR78546B (enExample) | 1984-09-27 |
| PT76609B (en) | 1986-01-17 |
| FI831426A0 (fi) | 1983-04-26 |
| ATA154883A (de) | 1987-06-15 |
| FI74467B (fi) | 1987-10-30 |
| FI831426L (fi) | 1983-10-30 |
| DK192683D0 (da) | 1983-04-28 |
| IT1194215B (it) | 1988-09-14 |
| FR2526020A1 (fr) | 1983-11-04 |
| IT8320779A0 (it) | 1983-04-26 |
| HU188274B (en) | 1986-03-28 |
| NO831503L (no) | 1983-10-31 |
| CH660485A5 (de) | 1987-04-30 |
| DE3315299A1 (de) | 1983-11-03 |
| YU95583A (en) | 1986-12-31 |
| ES8406476A1 (es) | 1984-07-01 |
| NL8301505A (nl) | 1983-11-16 |
| CS233748B2 (en) | 1985-03-14 |
| IT8320779A1 (it) | 1984-10-26 |
| IL68505A (en) | 1986-01-31 |
| CA1192548A (en) | 1985-08-27 |
| SE8302411D0 (sv) | 1983-04-28 |
| PT76609A (en) | 1983-05-01 |
| AU1399183A (en) | 1983-11-03 |
| AU557703B2 (en) | 1987-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU656859B2 (en) | Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent | |
| US5428040A (en) | Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents | |
| EP0127135B1 (en) | Fused tricyclic derivatives of naphthyridinone and pyridone and the corresponding thiones | |
| US4675319A (en) | Antianaphylactic and antibronchospastic piperazinyl-(N-substituted phenyl)carboxamides, compositions and use | |
| KR20140023341A (ko) | 항신생물제로서의3- 및 4환성 피라졸로[3,4-b]피리딘 화합물 | |
| PL175932B1 (pl) | Nowe imidazopirydyny, sposób wytwarzania nowych imidazopirydyn i środek leczniczy zawierający nowe imidazopirydyny | |
| JPH0366311B2 (enExample) | ||
| JPH09301958A (ja) | 新規ピリミジン化合物及び抗ロタウイルス剤 | |
| US4013665A (en) | Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines | |
| PL125321B1 (en) | Process for preparing novel,condensed derivatives of pyrimidines | |
| PL190803B1 (pl) | Związki tetrahydropirydylowe, środki farmaceutyczne zawierające te związki oraz zastosowanie tych związków | |
| US4565815A (en) | Pyrazolo[1,5-a]-1,3,5-triazines | |
| US4239887A (en) | Pyridothienotriazines | |
| FI74467C (fi) | Foerfarande foer framstaellning av 1,2,3,10-tetrahydro-10-oxo-cyklopenta/d/pyrido/1,2-a/pyrimidin- och 1,2,3,4-tetrahydro-11-oxo-11h-pyrido/2,1-b/kinazolinderivat. | |
| US3992380A (en) | 5,8-Dihydro-5-oxo-2-(4-or 3-pyridinyl)pyrido[2,3-d]pyrimidine-6-carboxylic acids and esters | |
| CS244107B2 (en) | Method of substituted pyrdoido-(1,2-a)pyrimidines production | |
| SK197A3 (en) | Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use | |
| US4447361A (en) | Aryl substituted pyrido[1,4]benzodiazepines | |
| JPH0762017B2 (ja) | 多環式キノリン、ナフチリジンおよびピラジノピリジン誘導体 | |
| FI74470C (fi) | Foerfarande foer framstaellning av 5-pyridyletenylderivat av 1h-pyrazolo/1,5-a/pyrimidiner. | |
| JP2531678B2 (ja) | トリアゾロピリダジン誘導体 | |
| JPH0386884A (ja) | ベンゾピラノピリジン誘導体 | |
| SU1340587A3 (ru) | Способ получени производных конденсированных бензопиронов или их фармацевтически приемлемых солей | |
| JPH04502475A (ja) | １，２―ジヒドロ―２―オキソキノキサリンの新規誘導体、その製造および治療への該化合物の適用 | |
| GB2119795A (en) | Condensed cycloaliphatic derivatives of substituted pyrido [1,2-a] pyrimidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: FARMITALIA CARLO ERBA S.P.A |